Search research articles
Contact Us
Filters
Showing results (1021-1030 of 1,059) with videos related to
Page
of 106
Sort By:
Cancer Research
|
September 3, 2004
A missense mutation in KIT kinase domain 1 correlates with imatinib resistance in gastrointestinal stromal tumors
Lei L Chen, Jonathan C Trent, Elsie F Wu, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 27, 2016
Improved Axillary Evaluation Following Neoadjuvant Therapy for Patients With Node-Positive Breast Cancer Using Selective Evaluation of Clipped Nodes: Implementation of Targeted Axillary Dissection
Abigail S Caudle, Wei T Yang, Savitri Krishnamurthy, et al.
The Lancet. Oncology
|
November 7, 2022
Hypofractionated, 3-week, preoperative radiotherapy for patients with soft tissue sarcomas (HYPORT-STS): a single-centre, open-label, single-arm, phase 2 trial
B Ashleigh Guadagnolo, Roland L Bassett, Devarati Mitra, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
March 24, 2025
Large-scale combination screens reveal small-molecule sensitization of antibiotic-resistant gram-negative ESKAPE pathogens
Megan W Tse, Meilin Zhu, Benjamin Peters, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
November 1, 2018
Three-Year Outcomes With Hypofractionated Versus Conventionally Fractionated Whole-Breast Irradiation: Results of a Randomized, Noninferiority Clinical Trial
Simona F Shaitelman, Xiudong Lei, Alastair Thompson, et al.
JAMA
|
October 9, 2013
Sentinel lymph node surgery after neoadjuvant chemotherapy in patients with node-positive breast cancer: the ACOSOG Z1071 (Alliance) clinical trial
Judy C Boughey, Vera J Suman, Elizabeth A Mittendorf, et al.
Blood Advances
|
June 27, 2018
Refining risk classification in childhood B acute lymphoblastic leukemia: results of DFCI ALL Consortium Protocol 05-001
Lynda M Vrooman, Traci M Blonquist, Marian H Harris, et al.
Plos Medicine
|
June 19, 2009
DEAR1 is a dominant regulator of acinar morphogenesis and an independent predictor of local recurrence-free survival in early-onset breast cancer
Steven T Lott, Nanyue Chen, Dawn S Chandler, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc
|
June 22, 2021
Breast implant-associated anaplastic large cell lymphoma: clinical follow-up and analysis of sequential pathologic specimens of untreated patients shows persistent or progressive disease
Mark G Evans, L Jeffrey Medeiros, Mario L Marques-Piubelli, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
July 6, 2021
Efficacy and Toxicity of Pegaspargase and Calaspargase Pegol in Childhood Acute Lymphoblastic Leukemia: Results of DFCI 11-001
Lynda M Vrooman, Traci M Blonquist, Kristen E Stevenson, et al.
Page
of 106
Search research articles
Search
Showing results (1021-1030 of 1,059) with videos related to
Sort By:
Page
of 106
Cancer Research
|
September 3, 2004
A missense mutation in KIT kinase domain 1 correlates with imatinib resistance in gastrointestinal stromal tumors
Lei L Chen, Jonathan C Trent, Elsie F Wu, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 27, 2016
Improved Axillary Evaluation Following Neoadjuvant Therapy for Patients With Node-Positive Breast Cancer Using Selective Evaluation of Clipped Nodes: Implementation of Targeted Axillary Dissection
Abigail S Caudle, Wei T Yang, Savitri Krishnamurthy, et al.
The Lancet. Oncology
|
November 7, 2022
Hypofractionated, 3-week, preoperative radiotherapy for patients with soft tissue sarcomas (HYPORT-STS): a single-centre, open-label, single-arm, phase 2 trial
B Ashleigh Guadagnolo, Roland L Bassett, Devarati Mitra, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
March 24, 2025
Large-scale combination screens reveal small-molecule sensitization of antibiotic-resistant gram-negative ESKAPE pathogens
Megan W Tse, Meilin Zhu, Benjamin Peters, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
November 1, 2018
Three-Year Outcomes With Hypofractionated Versus Conventionally Fractionated Whole-Breast Irradiation: Results of a Randomized, Noninferiority Clinical Trial
Simona F Shaitelman, Xiudong Lei, Alastair Thompson, et al.
JAMA
|
October 9, 2013
Sentinel lymph node surgery after neoadjuvant chemotherapy in patients with node-positive breast cancer: the ACOSOG Z1071 (Alliance) clinical trial
Judy C Boughey, Vera J Suman, Elizabeth A Mittendorf, et al.
Blood Advances
|
June 27, 2018
Refining risk classification in childhood B acute lymphoblastic leukemia: results of DFCI ALL Consortium Protocol 05-001
Lynda M Vrooman, Traci M Blonquist, Marian H Harris, et al.
Plos Medicine
|
June 19, 2009
DEAR1 is a dominant regulator of acinar morphogenesis and an independent predictor of local recurrence-free survival in early-onset breast cancer
Steven T Lott, Nanyue Chen, Dawn S Chandler, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc
|
June 22, 2021
Breast implant-associated anaplastic large cell lymphoma: clinical follow-up and analysis of sequential pathologic specimens of untreated patients shows persistent or progressive disease
Mark G Evans, L Jeffrey Medeiros, Mario L Marques-Piubelli, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
July 6, 2021
Efficacy and Toxicity of Pegaspargase and Calaspargase Pegol in Childhood Acute Lymphoblastic Leukemia: Results of DFCI 11-001
Lynda M Vrooman, Traci M Blonquist, Kristen E Stevenson, et al.
Page
of 106